with Vena Caval Umbrella
|
|
- Mervyn Marshall
- 5 years ago
- Views:
Transcription
1 Prevention of Pulmonary Embolus with Vena Caval Umbrella Results in 150 Patients Thomas 0. Orvald, M.D., George M. Callard, M.D., and James R. Jude, M.D. ABSTRACT A simple technique for effectively interrupting the inferior vena cava in patients with pulmonary emboli was introduced in The effectiveness of this method was evaluated in 150 patients having vena caval umbrella insertion following diagnosis of pulmonary embolism. These patients have been followed from two months to three years. The untoward sequelae and complications of insertion have been few. There have been 3 instances of documented pulmonary emboli occurring after insertion of the vena caval umbrella. Postoperative vena cavograms were obtained in 16 patients, and the patency was determined. The incidence of significant postoperative sequelae was directly related to the presence of preexisting venous disease. Only 1 death was directly attributed to vena caval umbrella insertion. Mortality figures reflect the fact that many of the patients were critically ill. The mortality in most cases was due to the underlying disease and not directly related to caval interruption itself. P ulmonary embolism continues to cause an estimated 50,000 in-hospital deaths annually in the United States. Mindful of the potentially lethal nature of the disease, physicians have responded with a number of therapeutic approaches. Basically these have utilized two techniquesmedication to alter the coagulation mechanism and surgical interruption of venous pathways. Although controversy exists about the proper sequence and timing of its use, placing a ligature between the clot and the heart, as advocated by Ochsner [lo], is generally conceded to be the most effective means of aborting further pulmonary emboli. In 1967 a technique was introduced by Mobin-Uddin and colleagues [7] in which a prosthetic device is inserted through the internal jugular vein and positioned in the inferior vena cava. This, in effect, places an obstruction between the most frequent origin of pulmonary emboli and the heart. The virtue of the technique appears to be twofold: it is a minor procedure performed rapidly under local anesthesia; and, because of its design, it From the Department of Surgery, Section of Thoracic and Cardiovascular University of Miami School of Medicine, Miami, Fla. Accepted for publication July 10, Address reprint requests to Dr. Orvald, 6465 S. Yale, Suite 804, Tulsa, Okla Surgery, 196 THE ANNALS OF THORACIC SURGERY
2 Prevention of Pulmonary Embolus with Vena Caual Umbrella affords immediate protection against large emboli without completely interrupting the vena cava. Clinical Material and Methods Our experience with use of the vena caval umbrella following the diagnosis of pulmonary embolism forms the basis of this report. The effectiveness of the method as a simple means of preventing further, potentially lethal emboli was evaluated in 150 patients. Follow-up has been from two months to three years. There were 48 women and 102 men. Their average age was 55.5 years. The indications for caval interruption were: (1) recurrent episodes of pulmonary embolism in the face of adequate anticoagulation therapy; (2) a single major episode of pulmonary embolism; (3) contraindications to anticoagulant therapy; and (4) recurrent phlebitis with iliofemoral vein thrombosis. Operation was performed after one or more episodes of pulmonary embolism had occurred and in several patients in whom caval interruption was considered necessary to avoid threatened embolism. The majority of candidates were referred from the medical services with either evidence of myocardial disease or thrombophlebitis. Clinical impressions of pulmonary embolism were confirmed by means of pulmonary arteriography in 93 patients and lung scan in 27. The remaining group was diagnosed on purely clinical grounds. The significant predisposing factors and their relationship to ultimate mortality are presented in Table 1. A technique of insertion has been outlined in detail previously [6]. Briefly, the patient is taken to the operating room, where he is placed on a fluoroscopy table and the right side of his neck is prepared and draped. Using local anesthesia, the internal jugular vein is isolated and the capsule with the umbrella in place is inserted intraluminally. Under fluoroscopic control using the image intensifier, the umbrella is positioned within the inferior vena cava immediately below the renal veins. The umbrella is ejected TABLE 1. PREDISPOSING FACTORS AND THEIR RELATIONSHIP TO ULTIMATE MORTALITY IN 150 PATIENTS WITH THE DIAGNOSIS OF PULMONARY EMBOLISM Factor No. of Patients Deaths Venous disease (thrombophlebitis, varicose veins) Heart disease (CHF, MI, cor pulmonale) Postoperative Trauma Pelvic disease Malignancy Bedridden Unknown "Percentage of total deaths. CHF = congestive heart failure; MI = myocardial infarction (20.6%)a (46%) 25 7 (11%) 5 2 (3.2%) 3 1 (1.6%) 3 3 (4.7%) 6 2 (3.2%) 10 6 (9.5%) VOL. 15, NO. 2, FEBRUARY,
3 OKVALD ET AL. arid secured, the applicator is removed, and the small incision is closed. The entire procedure lasts an average of 30 minutes. If the patient had overt evidence of thrombophlebitis and no contraindications to the use of anticoagulants, intravenous aqueous heparin is given postoperatively. Roentgenography of the inferior vena cava was performed postoperatively in 19 patients. Ten of the vena cavas were open, and 9 were closed. M o?'tal i t y Only 1 patient died as a result of the procedure. This was a young patient who had septic pelvic thrombophlebitis following an abortion. She was seriously ill, and 24 hours following insertion became hypotensive and subsequently died. At postmortem examination a significant amount of blood was found in the retroperitoneal area adjacent to the position of the umbrella. It was believed that the umbrella had perforated the vena cava and that this contributed to her death. Sixty-three patients died in the immediate postoperative period and during the next six months following insertion of the umbrella. Postmortem examinations were obtained in 23 patients. Six deaths were proved to be secondary to pulmonary embolism, which was thought to have occurred following insertion in 2 patients. In the 4 patients who died and in whom significant pulmonary emboli were found at postmortem examination, the location and configuration of the emboli closely corresponded to that seen in the preoperative pulmonary arteriograms. Therefore it was believed that embolism had occurred prior to insertion of the umbrella. Fifty-seven of the deaths were secondary to other illnesses. The majority of the patients who died had significant heart disease as manifested by congestive heart failure or had had myocardial infarctions. The high mortality seen in patients with cardiac disease is similar to that in other series presented by Crane [3] and Nabseth and Moran [9]. Complications of Inseytion and Long-Teym Sequelae Complications directly related to the insertion of the umbrella are listed in Table 2. The most significant of these was a documented perforation of the vena cava, as discussed before under Mortality. There was 1 patient with pneumothorax and 2 cases of malpositioning in which the umbrella was TABLE 2. COMPLICATIONS OF VENA CAVAL UMBRELLA INSERTION IN 150 PATIENTS Complication No. of Patients Perforation 3 Malposi tion 2 Pneumothorax 1 Neck hematoma THE ANNALS OF THORACIC SURGERY
4 Preuention of Pulmonary Embolus with Vena Caual Umbrella TABLE 3. LATE SEQUELAE OF VENA CAVAL UMBRELLA INSERTION IN 150 PATIENTS Sequela No. of Patients Swelling Phlebitis 33 (37.80/,)a 16 (18.4y0) Pain, fatigue Ulcer 5 (5.7%) 2 (2.3%) 'Percentage of surviving patients. placed in the right iliac vein. A second umbrella was subsequently inserted in the proper position in 1 of these patients. The other malpositioned umbrella was allowed to remain in place, and although no further embolism occurred, was removed because of persistent pain. The significant sequelae are listed in Table 3. The late sequelae found in the 87 patients surviving more than six months were all related to venous stasis. Many of these survivors developed transitory edema immediately after operation, but this disappeared following elevation and compression of the legs. The majority of patients with serious venous stasis problems had a history of preexisting venous disease. In the long-term survivors (two years) there was slight edema in 35 patients. Incidence of Recurrent Emboli There were 3 documented recurrences of pulmonary emboli, an incidence of Zyo. Two of these were fatal, and at postmortem examination fresh emboli were demonstrated, as discussed before under Mortality. In 1 patient, clinical findings were suggestive of recurrent emboli and pulmonary angiography was confirmatory. This patient was placed on anticoagulant therapy, and no further episodes occurred. The effectiveness of the vena caval umbrella method of preventing TABLE 4. SURGICAL METHODS OF TREATING PULMONARY EMBOLI- COMPARATIVE EXPERIENCE" No. with No. with Method & No. of Recurrent Recurrent Author Patients Embolism Fatal Embolism Femoral vein ligation Crane [3] Mozes et al. [S] Inferior vena cava ligation Blalock et al. [2] Crane [3] Mozes et al. [8] Nabseth & Moran [9] Orvald et al. [present report] 'After Nabseth and Moran [9] (10%) 13 (5%) (26.4%) 10 (8.2%) VOL. 15, NO. 2, FEBRUARY,
5 ORVALD ET AL. TABLE 5. OPERATIVE MORTALITY WITH INFERIOR VENA CAVA INTERRUPTION PROCEDURES Source of Data Mortality (yo) Mozes et al. [8] 5.4 Donaldson et al. r Nabseth & Moran Orvald et al. [present report] < 1.0 pulmonary embolism can be compared to that in other large series of venous ligation techniques (Table 4). Femoral vein ligation provides inadequate protection against emboli. Vena caval ligation confers excellent protection but carries a significant mortality from the operative procedure itself, especially when performed on seriously ill patients. The comparative operative mortality figures from several large inferior vena caval ligation series is presented in Table 5. Comment The most alarming figure in our series is the fearsome overall mortality rate of 42y0. It is important, however, to evaluate these figures in the light of our take all comers attitude. A significant number of the patients having vena caval umbrellas inserted were in moribund condition at the time of the operation. Most of these had severe congestive heart failure secondary to coronary artery disease, valvular disease, or cor pulmonale. In spite of this, only 2 patients died as a result of proved recurrent pulmonary emboli, and only 1 died as a direct result of the operation. It is well recognized that the in-hospital mortality after ligation of the inferior vena cava in patients with congestive heart failure is high. Nabseth and Moran [9] reported a mortality rate of 41%, Crane [3] had a 21% mortality, and 20% of the patients of Mozes and associates [S] died. In evaluating the various methods of treatment, it is important to consider not only the effectiveness of prevention of further emboli but also the mortality rate of the operative procedure. These figures must in turn be compared with the expected incidence and mortality of recurrent pulmonary emboli in untreated patients. Barker and his colleagues [l], in a postoperative review of 1,665 patients having had a nonfatal pulmonary embolus and no specific treatment, reported a 31ojb likelihood of recurrent embolism and an lsyo chance of recurrent fatal embolus. The mortality rate for each episode of embolism of a magnitude sufficient to produce symptoms is reported by Dexter [4] to be between 20 and 38y0. In view of the above statistics, it would appear that our operative mortality of <l.oyo, recurrent embolism rate of 2yo, and low morbidity rate provide convincing evidence of the worthwhile results obtained with use of the vena caval umbrella in preventing pulmonary embolism. 200 THE ANNALS OF THORACIC SURGERY
6 References Prevention of Pulmonary Embolus with Vena Caval Umbrella Barker, N. W., Nygaard, K. K., Walters, W., and Priestley, J. 7'. A statistical study of postoperative venous thrombosis and pulmonary embolism: Time of occurrence during operative period. Proc. Stag Meet. Mayo Clin. 16: 17, Blalock, J. B., Meyer, K., and Dukes, W. F. Treatment of thromboembolic disease by ligation of the inferior vena cava. R.Z. Med. J. 42:441, Crane, C. Femoral vs. caval interruption for venous thromboembolism. N. Engl. J. Med. 270:819, Dexter, L. Pulmonary Embolism and Acute Cor Pulmonale. In I. W. Hurst and R. Logue (Eds.), 'The Heart (2d ed.). New York: McGraw-Hill, P Donaldson, G. A., Linton, K. R., and Kodkey, G. V. Twenty year survey of thromboembolism at Massachusetts General Hospital, N. Engl. J. Med. 265:208, Mobin-Uddin, K., McLean, R., Bolooki, H., and Jude, J. R. Caval interruption for prevention of pulmonary embolism. Arch. Surg. 99:711, Mobin-Uddin, K., Smith, P. E., Martinez, L. D., Lombardo, C. R., and Jude, J. R. A vena caval filter for the prevention of pulmonary embolus. Surg. Forum 18:209, Mozes, M., Adar, R., Bogokowsky, H., and Agmon, M. Vein ligation in treatment of pulmonary embolism. Surgery 55521, Nabseth, D. C., and Moran, J. M. Reassessment of the role of inferior-venacava ligation in venous thromboembolism. N. Engl. J. Med. 273:1250, Ochsner, A. Indications for and results of inferior vena caval ligation for thromboembolic disease. Postgrad. Med. 27: 193, VOL. 15, NO. 2, FEBRUARY,
Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine
Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine Venous thromboembolism: pulmonary embolism (PE) deep vein thrombosis (DVT) 1% of all patients admitted to hospital 5% of in-hospital mortality
More informationSurgical approach for DVT. Division of Vascular Surgery Department of Surgery Seoul National University College of Medicine
Surgical approach for DVT Seung-Kee Min Division of Vascular Surgery Department of Surgery Seoul National University College of Medicine Treatment Options for Venous Thrombosis Unfractionated heparin &
More informationA A U
PVD Venous AUC Rating Sheet 2nd Round 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Median I NI MADM Rating Agree Disagree Upper Extremity Venous Evaluation Table 1. Venous Duplex of the Upper Extremities for Patency
More informationNOTE: Deep Vein Thrombosis (DVT) Risk Factors
Deep Vein Thrombosis (DVT) Deep Vein Thrombosis (DVT) is the formation of a blood clot, known as a thrombus, in the deep leg vein. It is a very serious condition that can cause permanent damage to the
More informationInferior Venacaval Filters Valuable vs. Dangerous Valuable Annie Kulungowski. Department of Surgery Grand Rounds March 24, 2008
Inferior Venacaval Filters Valuable vs. Dangerous Valuable Annie Kulungowski Department of Surgery Grand Rounds March 24, 2008 History of Vena Cava Filters Virchow-1846-Proposes PE originate from veins
More informationOn Which Criteria Do You Select Your Stent for Ilio-femoral Venous Obstruction? North American Point of View
On Which Criteria Do You Select Your Stent for Ilio-femoral Venous Obstruction? North American Point of View Peter Gloviczki, MD Ying Huang, MD, PhD Division of Vascular and Endovascular Surgery, Mayo
More informationClinical Guide - Inferior Vena Cava Filters (Reviewed 2006)
Clinical Guide - Inferior Vena Cava Filters (Reviewed 2006) Principal Developer: V. Oliva Secondary Developers: W. Geerts Background The treatment of choice for deep venous thrombosis (DVT) and pulmonary
More informationStarting with deep venous treatment
Starting with deep venous treatment Carsten Arnoldussen, MD Interventional Radiologist Maastricht University Medical Centre, Maastricht VieCuri Medical Centre, Venlo The Netherlands Background Maastricht
More informationDEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
M AY. 6. 2011 10:37 A M F D A - C D R H - O D E - P M O N O. 4147 P. 1 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control
More informationUltrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism A pulmonary embolism (PE) is
More informationMabel Labrada, MD Miami VA Medical Center
Mabel Labrada, MD Miami VA Medical Center *1-Treatment for acute DVT with underlying malignancy is for 3 months. *2-Treatment of provoked acute proximal DVT can be stopped after 3months of treatment and
More informationIVC Filters: Rate of Insertion, Indications, Effects on Prognosis, Evidence Basis for Current Practices. Paul D. Stein, MD
IVC Filters: Rate of Insertion, Indications, Effects on Prognosis, Evidence Basis for Current Practices Paul D. Stein, MD Professor Department of Osteopathic Medical Specialties College of Osteopathic
More informationPULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT
PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT OBJECTIVE: To provide a diagnostic algorithm and treatment options for patients with acute pulmonary embolism (PE). BACKGROUND: Venous thromboembolism (VTE)
More informationHow to best approach chronic venous occlusions?
How to best approach chronic venous occlusions? Prof. Nils Kucher Director Venous Thromboembolism Reseach Group University Hospital Bern nilskucher.com Disclosure Speaker name: Nils Kucher X X I have the
More informationEndovascular treatment of acquired arteriovenous fistula with severe hemodynamic effects: a case report
Endovascular treatment of acquired arteriovenous fistula with severe hemodynamic effects: a case report The Leipzig Interventional Course, January 24 27, 2017 El Samman K., Šedivý P., Šnajdrová A., Přindišová
More informationThrombolysis in PE. Outline. Disclosure. Overview on Pulmonary Embolism. Hot Topics in Emergency Medicine 2012 Midyear Clinical Meeting
Disclosure Thrombolysis in PE Daniel P. Hays, PharmD, BCPS, FASHP reports no relevant financial relationships. Daniel P. Hays, PharmD, BCPS, FASHP Outline 55 YOF presents to ED with SOB PMH of DVT + noncompliance
More informationIVC Filters: For Whom, Why and When?
IVC Filters: For Whom, Why and When? Dariusz Zawierucha, MD Interventional & Diagnostic Radiology Radiology Associates, PC 1 Disclosures: I have no financial conflicts to disclose. I do not endorse any
More informationHow long to continue anticoagulation after DVT?
How long to continue anticoagulation after DVT? Dr. Nihar Ranjan Pradhan M.S., DNB (Vascular Surgery), FVES(UK) Consultant Vascular Surgeon Apollo Hospital, Jubilee Hills, Hyderabad (Formerly Faculty in
More informationDisturbance of Circulation Hemodynamic Disorder
Disturbance of Circulation Hemodynamic Disorder 2/17/2017 By Dr. Hemn Hassan Othman PhD, Pathology Fall 2016 1 Thrombosis Definition: Thrombosis is the formation of solid or semisolid blood clot within
More informationInferior Vena Cava Filters- Are they Followed up? By Dr Nathalie van Havre Dr Chamica Wijesinghe Dr Kieren Brown
Inferior Vena Cava Filters- Are they Followed up? By Dr Nathalie van Havre Dr Chamica Wijesinghe Dr Kieren Brown Introduction Trousseau (1868) first described interruption to inferior vena cava (IVC) to
More informationPREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM
PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM International Consensus Statement 2013 Guidelines According to Scientific Evidence Developed under the auspices of the: Cardiovascular Disease Educational
More informationCombined oral contraceptives and risk of venous thromboembolism: nested case control studies using the QResearch and the CPRD databases
Combined oral contraceptives and risk of venous thromboembolism: nested case control studies using the QResearch and the CPRD databases Yana Vinogradova, Carol Coupland, Julia Hippisley-Cox Web appendix:
More informationDVT - initial management NSCCG
Background information Information resources for patients and carers Updates to this care map Synonyms Below knee DVT and bleeding risks Patient with confirmed DVT Scan confirms superficial thrombophlebitis
More informationINFERIOR VENA CAVA FILTERS QUIZ 10 QUESTIONS MAY 5, 2014
INFERIOR VENA CAVA FILTERS QUIZ 10 QUESTIONS MAY 5, 2014 QUESTION 1 1. Anatomically Transposition of the IVC is observed in what % of individuals A) 1-5% B).2-.05% C) 3-5% D) 5-10% ANSWER QUESTION 1 Answer
More informationInferior Vena Cava Filter for DVT
Inferior Vena Cava Filter for DVT Deep Vein Thrombosis A deep vein thrombosis (DVT) is a blood clot that forms in a deep vein. This is a serious condition that occurs more often than you might think. If
More informationDISORDERS OF VENOUS SYSTEM
DISORDERS OF VENOUS SYSTEM Varicose Veins Any dilated, elongated and tortuous vein irrespective of size Varicose veins are common in the superficial veins of the leg which are subject to high pressure
More informationHunter vena cava balloon: and results. Rationale. James A. Hunter, M.D., and Giacomo A. DeLaria, M.D., Chicago, Ill.
Hunter vena cava balloon: and results Rationale James A. Hunter, M.D., and Giacomo A. DeLaria, M.D., Chicago, Ill. The majority of patients with venous thromboembolism are successfully managed with anticoagulation
More informationListing Form: Heart or Cardiovascular Impairments. Medical Provider:
Listing Form: Heart or Cardiovascular Impairments Medical Provider: Printed Name Signature Patient Name: Patient DOB: Patient SS#: Date: Dear Provider: Please indicate whether your patient s condition
More informationInferior Vena Cava Filters
Inferior Vena Cava Filters and the American Society of Hematology Choosing Wisely Campaign Kevin P. Hubbard, DO, HMDC MACOI Chief - Division of Specialty Medicine Professor and Chair - Section of Internal
More informationCost-effective prevention of pulmonary embolus in high-risk trauma patients Brasel K J, Borgstrom D C, Weigelt J A
Cost-effective prevention of pulmonary embolus in high-risk trauma patients Brasel K J, Borgstrom D C, Weigelt J A Record Status This is a critical abstract of an economic evaluation that meets the criteria
More informationInterventional Treatment VTE: Radiologic Approach
Interventional Treatment VTE: Radiologic Approach Hae Giu Lee, MD Professor, Dept of Radiology Seoul St. Mary s Hospital The Catholic University of Korea Introduction Incidence High incidence: 250,000-1,000,000/year
More informationIntervention for Deep Venous Thrombosis and Pulmonary Embolus
Intervention for Deep Venous Thrombosis and Pulmonary Embolus Michael R. Jaff, DO Paul and Phyllis Fireman Endowed Chair in Vascular Medicine Massachusetts General Hospital Professor of Medicine Harvard
More informationImaging abdominal vascular emergencies. V.Stoynova
Imaging abdominal vascular emergencies V.Stoynova Abdominal vessels V. Stoynova 2 Acute liver bleeding trauma anticoagulant therapy liver disease : HCC, adenoma, meta, FNH, Hemangioma Diagnosis :CT angiography
More informationI-Ming Chen, MD. Endovascular Stenting for Palliative Treatment of Superior Vena Cava Syndrome in End-Stage Lung Cancer
Endovascular Stenting for Palliative Treatment of Superior Vena Cava Syndrome in End-Stage Lung Cancer I-Ming Chen, MD Division of CardioVascular Surgery Taipei Veterans General Hospital, Taiwan (Live
More informationSupplementary Online Content
Supplementary Online Content Mismetti P, Laporte S, Pellerin O, Ennezat P-V, Couturaud F, Elias A, et al. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone
More informationHemodynamic Disorders, Thrombosis, and Shock. Richard A. McPherson, M.D.
Hemodynamic Disorders, Thrombosis, and Shock Richard A. McPherson, M.D. Edema The accumulation of abnormal amounts of fluid in intercellular spaces of body cavities. Inflammation and release of mediators
More informationI am NOT: Disclosures. The Problem of the Con-Position Non Thinking! Against New Ideas. Against New Therapies. Against Endovascular Therapies
Inferior Vena Cava Filters: Disclosures A Love /Hate (Mostly Hate) Relationship Lack of Political Correctness Gregory L. Moneta, M.D. Professor and Chief, Vascular Surgery Oregon Health & Science University
More informationVascular Surgery Rotation Objectives for Junior Residents (PGY-1 and 2)
Vascular Surgery Rotation Objectives for Junior Residents (PGY-1 and 2) Definition Vascular surgery is the specialty concerned with the diagnosis and management of congenital and acquired diseases of the
More informationChapter 4 Section 9.1
Surgery Chapter 4 Section 9.1 Issue Date: August 26, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) 1.0 CPT 1 PROCEDURE CODES 33010-33130, 33140, 33141, 33200-37186, 37195-37785, 92950-93272, 93303-93581,
More informationCURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow
CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM Gordon Lowe Professor of Vascular Medicine University of Glasgow VENOUS THROMBOEMBOLISM Common cause of death and disability 50% hospital-acquired
More informationMeissner MH, Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, et al. J Vasc Surg. 2012;55:
Early thrombus removal strategies for acute deep venous thrombosis: Clinical Practice Guidelines of the Society for Vascular Surgery and the American Venous Forum Meissner MH, Gloviczki P, Comerota AJ,
More informationListen to Your Heart. What Everyone Needs To Know About Atrial Fibrillation & Stroke. The S-ICD System. The protection you need
Listen to Your Heart The S-ICD System What Everyone Needs To Know About Atrial Fibrillation & Stroke The protection you need without Stroke. touching Are you your at heart risk? Increase your knowledge.
More informationSaphenous Vein Autograft Replacement
Saphenous Vein Autograft Replacement of Severe Segmental Coronary Artery Occlusion Operative Technique Rene G. Favaloro, M.D. D irect operation on the coronary artery has been performed in 180 patients
More informationInferior vena cava interruption with the Hunter-Sessions balloon: Eighteen years' experience in 191 cases
Inferior vena cava interruption with the Hunter-Sessions balloon: Eighteen years' experience in 191 cases lames A. Hunter, M_D, Giacomo A. DeLaria, MD, Marshall D. Goldin, MD, Cyrus Serry, MD, David O.
More informationInfarction. marol). This conclusion was based upoli all. analysis of 424 cases of acute myocardial. infarction which were treated by conservative
Indications for Bishydroxycouinarin (Dicumarol) in Acute Myocardial Infarction By HENRY I. RUSSEK, AII.D., BURTON L. ZOHMAN, M.D., ALEXANDER A. DOERNER, M.D., ALLEN S. RuSSEK, M.D., AND LAVERE G. WHITE,
More informationNot all Leg DVT s are the Same: Which Patients Benefit from Interventional Therapy? Case 1:
12/16/2015 Not all Leg DVT s are the Same: Which Patients Benefit from Interventional Therapy? Constantino S.Peña, FSIR, FSCCT, FAHA Interventional Radiologist Medical Director, Vascular Imaging Miami
More informationCMS Limitations Guide - Radiology Services
CMS Limitations Guide - Radiology Services Starting October 1, 2015, CMS will update their existing medical necessity limitations on tests and procedures to correspond to ICD-10 codes. This limitations
More informationJordan M. Garrison, MD FACS, FASMBS
Jordan M. Garrison, MD FACS, FASMBS Peripheral Arterial Disease (PAD) Near or Complete obstruction of > 1 Peripheral Artery Peripheral Venous reflux Disease Varicose Veins Chronic Venous Stasis Ulcer Disease
More informationManagement of Post-Thrombotic Syndrome
Management of Post-Thrombotic Syndrome Thanainit Chotanaphuti Phramongkutklao College of Medicine Bangkok, Thailand President of CAOS Asia President of Thai Hip & Knee Society President of ASEAN Arthroplasty
More informationPATCHING AND SECTION OF THE PULMONARY ORIFICE OF THE HEART.*
Published Online: 1 July, 1914 Supp Info: http://doi.org/10.1084/jem.20.1.3 Downloaded from jem.rupress.org on December 24, 2018 PATCHING AND SECTION OF THE PULMONARY ORIFICE OF THE HEART.* BY THEODORE
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/19768 holds various files of this Leiden University dissertation. Author: Langevelde, Kirsten van Title: Are pulmonary embolism and deep-vein thrombosis
More informationComplications of ECLS. Rajasekhar Malyala, MD Assistant Professor, Surgery University of Kentucky
Complications of ECLS Rajasekhar Malyala, MD Assistant Professor, Surgery University of Kentucky Faculty Disclosure No financial Disclosures Education Need/Practice Gap Recommendations and guidelines regarding
More informationPatient guide: pfm Nit-Occlud PDA coil occlusion system. Catheter occlusion of. Patent Ductus Arteriosus. with the
Patient guide: Catheter occlusion of Patent Ductus Arteriosus with the pfm Nit-Occlud PDA coil occlusion system pfm Produkte für die Medizin - AG Wankelstr. 60 D - 50996 Cologne Phone: +49 (0) 2236 96
More informationChapter 1. Introduction
Chapter 1 Introduction Introduction 9 Even though the first reports on venous thromboembolism date back to the 13 th century and the mechanism of acute pulmonary embolism (PE) was unraveled almost 150
More informationChapter 4 Section 9.1
Surgery Chapter 4 Section 9.1 Issue Date: August 26, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) 1.0 CPT 1 PROCEDURE CODES 33010-33130, 33140, 33141, 33361-33369, 33200-37186, 37195-37785, 92950-93272,
More informationDeep Vein Thrombosis and Pulmonary Embolism: Patient Information
Deep Vein Thrombosis and Pulmonary Embolism: Patient Information A Deep Vein Thrombosis (DVT) and a Pulmonary Embolism (PE) are both disorders of unwanted blood clotting. Unwanted blood clots can occur
More informationIndications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014
Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such
More informationVTE Management in Surgical Patients: Optimizing Prophylaxis Strategies
VTE Management in Surgical Patients: Optimizing Prophylaxis Strategies VTE in Surgical Patients: Recognizing the Patients at Risk Pathogenesis of thrombosis: Virchow s triad and VTE Risk Hypercoagulability
More informationVENOUS THROMBOEMBOLISM: DURATION OF TREATMENT
VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT OBJECTIVE: To provide guidance on the recommended duration of anticoagulant therapy for venous thromboembolism (VTE). BACKGROUND: Recurrent episodes of VTE
More informationWhat You Should Know
1 New 2018 ASH Clinical Practice Guidelines on Venous Thromboembolism: What You Should Know New 2018 ASH Clinical Practice Guidelines on Venous Thromboembolism: What You Should Know The American Society
More informationCOMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)
The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 16 December 1999 COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) NOTE FOR GUIDANCE ON CLINICAL
More informationVenous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community
Venous Thrombosis Venous Thrombosis It occurs mainly in the deep veins of the leg (deep vein thrombosis, DVT), from which parts of the clot frequently embolize to the lungs (pulmonary embolism, PE). Fewer
More informationDetailed Order Request Checklists for Cardiology
Next Generation Solutions Detailed Order Request Checklists for Cardiology 8600 West Bryn Mawr Avenue South Tower Suite 800 Chicago, IL 60631 www.aimspecialtyhealth.com Appropriate.Safe.Affordable 2018
More information1. SCOPE of GUIDELINE:
Page 1 of 35 CLINICAL PRACTICE GUIDELINE: Venous Thromboembolism (VTE) Prevention Guideline: Thromboprophylaxis AUTHORIZATION: VP, Medicine Date Approved: May 17, 2012 Date Revised: Vancouver Coastal Health
More informationRight-Sided Bacterial Endocarditis
New Concepts in the Treatment of the Uncontrollable Infection Agustin Arbulu, M.D., Ali Kafi, M.D., Norman W. Thorns, M.D., and Robert F. Wilson, M.D. ABSTRACT Our experience with 25 patients with right-sided
More informationClinical results of venous stents. Michael K. W. Lichtenberg MD, FESC
Clinical results of venous stents Michael K. W. Lichtenberg MD, FESC Conflict of Interest - Disclosure Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement or affiliation
More informationOctober 2017 Pulmonary Embolism
October 2017 Pulmonary Embolism Prof. Ahmed BaHammam, FRCP, FCCP Professor of Medicine College of Medicine King Saud University 1 Objectives Epidemiology Pathophysiology Diagnosis Massive PE Treatment
More informationA treatment option for varicose veins. enefit" Targeted Endovenous Therapy. Formerly known as the VNUS Closure procedure E 3 COVIDIEN
A treatment option for varicose veins. enefit" Targeted Endovenous Therapy Formerly known as the VNUS Closure procedure E 3 COVIDIEN THE VENOUS SYSTEM ANATOMY The venous system is made up of a network
More informationTop Ten Reasons For Failure To Prevent Postoperative Thrombosis
Top Ten Reasons For Failure To Prevent Postoperative Thrombosis Joseph A. Caprini, MD, MS, FACS, RVT, FACCWS Louis W. Biegler Chair of Surgery NorthShore University HealthSystem, Evanston, IL Clinical
More informationDeep Vein Thrombosis
Deep Vein Thrombosis Introduction Deep vein thrombosis (DVT) is a blood clot in a vein. This condition can affect men and women of any age and race. DVT is a potentially serious condition. If not treated,
More informationDisclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None
Disclosures DVT: Diagnosis and Treatment None Susanna Shin, MD, FACS Assistant Professor University of Washington Acute Venous Thromboembolism (VTE) Deep Venous Thrombosis (DVT) Pulmonary Embolism (PE)
More informationPulmonary Emboli without Leg Symptoms, May-Thurner syndrome. Case Report and Review
ISPUB.COM The Internet Journal of Internal Medicine Volume 9 Number 2 Pulmonary Emboli without Leg Symptoms, May-Thurner syndrome. Case Report and Review A Hamo, M Alyaseen, F Alkhankan, T Gress Citation
More informationPatency rates and clinical results of the Veniti VICI Stent for treatment of iliac vein lesion Data from the Arnsberg Venous Registry
Patency rates and clinical results of the Veniti VICI Stent for treatment of iliac vein lesion Data from the Arnsberg Venous Registry Michael K. W. Lichtenberg MD, FESC Conflict of Interest - Disclosure
More informationUseful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity?
Preoperative intraaortic balloon counterpulsation in high-risk CABG Stefan Klotz, M.D. Preoperative IABP in high-risk CABG Questions?? Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication
More informationRisk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD
Risk factors for DVT Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior
More informationVenous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD
Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Risk factors for DVT Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior
More information(This is a sample cover image for this issue. The actual cover is not yet available at this time.)
(This is a sample cover image for this issue. The actual cover is not yet available at this time.) This is an open access article which appeared in a journal published by Elsevier. This article is free
More informationClinical Medical Policy Department Clinical Affairs Division DESCRIPTION
Prothrombin Time/International Normalized Ratio (PT/INR) Monitor for Home Anticoagulation Management [For the list of services and procedures that need preauthorization, please refer to www.mcs.com.pr.
More informationDeep Vein Thrombosis and Pulmonary Embolism in the Perioperative Patient
...PRESENTATIONS... Deep Vein Thrombosis and Pulmonary Embolism in the Perioperative Patient Based on a presentation by James E. Muntz, MD Presentation Summary Approximately 500,000 cases of deep vein
More informationThe Johns Hopkins Hospital Patient Information. How Do I Prevent Blood Clots? Venous Thromboembolism (VTE) Deep Vein Thrombosis (DVT)
Page 1 of 11 Venous Thromboembolism () What is a clot or Venous Thromboembolism ()? Blood clots are called Venous Thromboembolism (). There are 2 main types: is a clot in a deep vein, usually an arm or
More informationLearning Objectives for Rotations in Vascular Surgery Year 3 Basic Clerkship
Learning Objectives for Rotations in Vascular Surgery Year 3 Basic Clerkship CLINICAL PROBLEMS IN VASCULAR SURGERY 1. ABDOMINAL AORTIC ANEURYSM A 70 year old man presents in the emergency department with
More informationPathology of pulmonary vascular disease. Dr.Ashraf Abdelfatah Deyab. Assistant Professor of Pathology Faculty of Medicine Almajma ah University
Pathology of pulmonary vascular disease Dr.Ashraf Abdelfatah Deyab Assistant Professor of Pathology Faculty of Medicine Almajma ah University Pulmonary vascular disease Type of pulmonary circulation: Types
More informationVenous Thromboembolism Prophylaxis
Approved by: Venous Thromboembolism Prophylaxis Vice President and Chief Medical Officer; and Vice President and Chief Operating Officer Corporate Policy & Procedures Manual Number: Date Approved January
More informationPulmonary Embolism. Thoracic radiologist Helena Lauri
Pulmonary Embolism Thoracic radiologist Helena Lauri 8.5.2017 Statistics 1-2 out of 1000 adults annually are diagnosed with deep vein thrombosis (DVT) and/or pulmonary embolism (PE) About half of patients
More informationSlide 1. Slide 2. Slide 3. Outline of This Presentation
Slide 1 Current Approaches to Venous Thromboembolism Prevention in Orthopedic Patients Hujefa Vora, MD Maria Fox, RN June 9, 2017 Slide 2 Slide 3 Outline of This Presentation Pathophysiology of venous
More informationINDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY
INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY N.E. Pearce INTRODUCTION Preventable death Cause of morbidity and mortality Risk factors Pulmonary embolism
More informationVASCULAR DISEASE: THREE THINGS YOU SHOULD KNOW JAMES A.M. SMITH, D.O. KANSAS VASCULAR MEDICINE, P.A. WICHITA, KANSAS
VASCULAR DISEASE: THREE THINGS YOU SHOULD KNOW JAMES A.M. SMITH, D.O. KANSAS VASCULAR MEDICINE, P.A. WICHITA, KANSAS KANSAS ASSOCIATION OF OSTEOPATHIC MEDICINE ANNUAL CME CONVENTION APRIL 13, 2018 THREE
More informationSpontaneous Tilting after Placement of the Gu nther-tulip Inferior Vena Caval Filter: A Case Report 1
Spontaneous Tilting after Placement of the Gu nther-tulip Inferior Vena Caval Filter: Case Report 1 Tae-Seok Seo, M.D., In-Ho Cha, M.D., Hae Young Seol, M.D., Cheol Min Park, M.D. Tilting of a deployed
More informationCarry this card with you at all times. Show this card to any medical professional treating you. Patient Implant Card. Option ELITE Vena Cava Filter.
Patient Guide A Safe Option for a Healthier You! P/N: P-2017-0175-00 Rev B 1. Static magnetic field of 3 Tesla or less. 2. Spatial gradient magnetic field of 720 Gauss/cm or less. 3. Maximum whole body
More informationProphylactic inferior vena cava filters in trauma patients at high risk: Follow-up examination and risk/benefit assessment
Prophylactic inferior vena cava filters in trauma patients at high risk: Follow-up examination and risk/benefit assessment Eugene M. Langan III, MD, Richard S. Miller, MD, William J. Casey III, MD, Christopher
More informationVenous Thrombosis. Magnitude of the Problem. DVT 2 Million PE 600,000. Death 60,000. Estimated Cost of VTE Care $1.5 Billion/year.
Venous Thrombosis Magnitude of the Problem DVT 2 Million Postthrombotic Syndrome 800,000 PE 600,000 Death 60,000 Silent PE 1 Million Pulmonary Hypertension 30,000 Estimated Cost of VTE Care $1.5 Billion/year
More informationIVC FILTERS: A CASE REPORT REVIEWING THE INDICATIONS FOR PLACEMENT, RETRIEVAL AND ANTICOAGULATION
IVC FILTERS: A CASE REPORT REVIEWING THE INDICATIONS FOR PLACEMENT, RETRIEVAL AND ANTICOAGULATION Resident(s): George Athanasatos Attending(s): Daniel Golwyn Program/Dept: Interventional Radiology CHIEF
More informationTop 5 (or so) Hematology Consults. Tom DeLoughery, MD FACP FAWM. Oregon Health and Sciences University DISCLOSURE
Top 5 (or so) Hematology Consults Tom FACP FAWM Oregon Health and Sciences University DISCLOSURE Relevant Financial Relationship(s) Speaker Bureau - None Consultant/Research none 1 What I am Talking About
More informationBILLING BULLETIN. Re: Interventional Cardiology. Bulletin #: 1. Date Issued: November 10, Background
BILLING BULLETIN Re: Interventional Cardiology Bulletin #: 1 Date Issued: November 10, 2016 Background This Billing Bulletin provides billing guidance when submitting claims to Manitoba Health, Seniors
More informationTHE popliteal artery is the second most common site of aneurysm. The
POPLITEAL ANEURYSM Treatment by Vein Graft: Case Report A. W. HUMPHRIES, M.D. Department of Orthopedic Surgery F. A. LeFEVRE, M.D. and V. G. dewolfe, M.D. Department of Cardiovascular Disease THE popliteal
More informationMRA/MRV CASE REVIEW. Carlos Avila R.T.(R)(MR)(CT)
MRA/MRV CASE REVIEW Carlos Avila R.T.(R)(MR)(CT) Carlso Avila, RT (R)(MR) No relevant financial relationship reported MRA/MRV Magnetic resonance angiography: noninvasive examination performed to evaluate
More informationVenous thromboembolism - reducing the risk
Venous thromboembolism - reducing the risk Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital NICE guideline Draft for consultation,
More informationIntended Learning Outcomes
2011 Acute Limb Ischemia Definition, Etiology & Pathophysiology Clinical Evaluation Management Ali SABBOUR Prof. of Vascular Surgery, Ain Shams University Acute Limb Ischemia Intended Learning Outcomes
More informationPercutaneously Inserted AngioVac Suction Thrombectomy for the Treatment of Filter-Related. Iliocaval Thrombosis
Percutaneously Inserted AngioVac Suction Thrombectomy for the Treatment of Filter-Related Iliocaval Thrombosis Faiz D. Francis, DO; Gianvito Salerno, MD; Sabbah D. Butty, MD Abstract In the setting of
More informationInteresting Cases - A Case Report: Renal Cell Carcinoma With Tumor Mass In IVC And Heart. O Wenker, L Chaloupka, R Joswiak, D Thakar, C Wood, G Walsh
ISPUB.COM The Internet Journal of Thoracic and Cardiovascular Surgery Volume 3 Number 2 Interesting Cases - A Case Report: Renal Cell Carcinoma With Tumor Mass In IVC And Heart O Wenker, L Chaloupka, R
More information